{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:22:49Z","timestamp":1761888169833,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia (English Edition)"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.repce.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T15:45:43Z","timestamp":1639583143000},"page":"911-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Suboptimal control of cardiovascular risk factors in myocardial infarction survivors in a cardiac rehabilitation program"],"prefix":"10.1016","volume":"40","author":[{"given":"Vasco","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Matos Vilela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilibeth","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Jo\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalena","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Fontes-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repce.2021.11.007_bib0255","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"issue":"10.","key":"10.1016\/j.repce.2021.11.007_bib0260","article-title":"Angina and future cardiovascular events in stable patients with coronary artery disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repce.2021.11.007_bib0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0270","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0275","doi-asserted-by":"crossref","first-page":"e014415","DOI":"10.1161\/JAHA.119.014415","article-title":"Cumulative adherence to secondary prevention guidelines and mortality after acute myocardial infarction","volume":"9","author":"Solomon","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repce.2021.11.007_bib0280","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.repce.2021.11.007_bib0285","doi-asserted-by":"crossref","first-page":"i2416","DOI":"10.1136\/bmj.i2416","article-title":"Prediction models for cardiovascular disease risk in the general population: systematic review","volume":"353","author":"Damen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.repce.2021.11.007_bib0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","article-title":"EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries","volume":"16","author":"Kotseva","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.repce.2021.11.007_bib0295","first-page":"391","article-title":"Practical guide for the use of PCSK9 inhibitors in Portugal","volume":"38","author":"Fontes-Carvalho","year":"2019","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0300","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0305","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials","volume":"61","author":"Farkouh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0310","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.repc.2019.02.009","article-title":"Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: data from the DISGEN-LIPID study","volume":"38","author":"da Silva","year":"2019","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0315","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2017.11.068","article-title":"Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials","volume":"71","author":"Pinho-Gomes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0320","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1177\/2047487316663873","article-title":"Challenges in secondary prevention after acute myocardial infarction: a call for action","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0325","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repce.2021.11.007_bib0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archinte.160.7.939","article-title":"Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies","volume":"160","author":"Wilson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repce.2021.11.007_bib0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12471-019-1269-7","article-title":"Different outcomes of a cardiac rehabilitation programme in functional parameters among myocardial infarction survivors according to ejection fraction","volume":"27","author":"Vilela","year":"2019","journal-title":"Neth Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0340","doi-asserted-by":"crossref","DOI":"10.1177\/2047487320905719","article-title":"Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: update of the Cardiac Rehabilitation Outcome Study (CROS-II)","author":"Salzwedel","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0350","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/2047487318781359","article-title":"Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey","volume":"25","author":"Kotseva","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0355","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa034","article-title":"Application of the 2019 ESC\/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study","author":"Allahyari","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/2047487315585293","article-title":"Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: data from the SWEDEHEART registry","volume":"23","author":"Hambraeus","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000504875","article-title":"Differential impact of a cardiac rehabilitation program on functional parameters in elderly versus non-elderly myocardial infarction survivors","volume":"145","author":"Vilela","year":"2020","journal-title":"Cardiology"},{"key":"10.1016\/j.repce.2021.11.007_bib0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0375","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.repce.2021.11.007_bib0380","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0385","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0395","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.repce.2021.11.007_bib0400","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repce.2021.11.007_bib0405","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90\u2013056 participants in 14 randomised trials of statins","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.repce.2021.11.007_bib0410","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.repce.2021.11.007_bib0415","doi-asserted-by":"crossref","first-page":"e0228472","DOI":"10.1371\/journal.pone.0228472","article-title":"Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.repce.2021.11.007_bib0420","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2047487319893035","article-title":"Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology","volume":"27","author":"Piepoli","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0425","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00392-016-1069-7","article-title":"Evidence-based goals in LDL-C reduction","volume":"106","author":"Soran","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0430","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12872-020-01616-9","article-title":"Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study","volume":"20","author":"Kristensen","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.repce.2021.11.007_bib0435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2020.05.055","article-title":"Current lipid lowering treatment and attainment of LDL targets recommended by ESC\/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: insights from the START registry","volume":"316","author":"De Luca","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0440","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.repce.2021.11.007_bib0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-018-0707-0","article-title":"Recent approaches to improve medication adherence in patients with coronary heart disease: progress towards a learning healthcare system","volume":"20","author":"Levy","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.repce.2021.11.007_bib0450","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.repce.2021.11.007_bib0455","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","article-title":"The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes","volume":"48","author":"King","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.repce.2021.11.007_bib0460","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.repce.2021.11.007_bib0465","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081114","article-title":"Long-term risk factor control after myocardial infarction \u2013 a need for better prevention programmes","volume":"8","author":"Osteresch","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.repce.2021.11.007_bib0470","first-page":"367","article-title":"Differential impact of a cardiac rehabilitation program in functional parameters according to patient gender","volume":"10","author":"Vilela","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.repce.2021.11.007_bib0475","first-page":"173","article-title":"Cardiac rehabilitation fitness changes and subsequent survival","volume":"4","author":"De Schutter","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.repce.2021.11.007_bib0480","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","article-title":"Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association","volume":"134","author":"Ross","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.repce.2021.11.007_bib0485","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0490","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/2047487319872660","article-title":"The 2016 Joint European Prevention Guidelines and the uses of polypills: time to update the evidence","volume":"27","author":"Webster","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.repce.2021.11.007_bib0495","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12872-020-01429-w","article-title":"Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey","volume":"20","author":"Goettler","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.repce.2021.11.007_bib0500","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082612","article-title":"Predictors of quitting smoking in cardiac rehabilitation","volume":"9","author":"Salman","year":"2020","journal-title":"J Clin Med"}],"container-title":["Revista Portuguesa de Cardiologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2174204921003603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2174204921003603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:41:42Z","timestamp":1761882102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2174204921003603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2174204921003603"],"URL":"https:\/\/doi.org\/10.1016\/j.repce.2021.11.007","relation":{},"ISSN":["2174-2049"],"issn-type":[{"type":"print","value":"2174-2049"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suboptimal control of cardiovascular risk factors in myocardial infarction survivors in a cardiac rehabilitation program","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repce.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2021.01.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}